Consumer satisfaction fuel ZERONA's continued placement growth.
FOR IMMEDIATE RELEASE / PRURGENT
DALLAS, Texas – 10/19/2012 - Primcogent Solutions announced today that another ZERONA laser device is in place at Clinica do Tempo, located at Edificio Monumental, Av. Praia da Vitória, n.º 71, 4º B, Lisboa, Portugal 1050-183.
Over the last year, Primcogent has seen a significant increase in ZERONA distribution and patient interest since the U.S. Food and Drug Administration granted market clearance for the non-invasive body contouring device. Over 1,125 ZERONA devices are in medical professional practices throughout North America who have treated in excess of 80,000 patients.
"We are extremely pleased with the continued interest of the ZERONA body contouring laser," said Michael Browning, Senior Vice President of Marketing and Business Development of Primcogent. "This strengthens ZERONA’s value in helping women and men transform their bodies in two weeks, with zero surgery, pain, bruising or recovery time."
ZERONA was granted market clearance by the FDA last year for the safe and effective circumferential reduction of the hips, waist and thighs. ZERONA uniquely targets fat cells and promotes the safe release of stored fats, a therapeutic approach that significantly differs from other technologies that intentionally destroy the known organ tissue by heating or freezing the cells.
To find a ZERONA Provider near you, go to www.FindZerona.com.
About Primcogent Solutions
Primcogent Solutions is dedicated to offering healthcare products to the medical community backed by a clear, logical, and convincing scientific and clinical foundation. Primcogent Solutions’ signature product, ZERONA, manufactured by Erchonia Medical is the only platform that is FDA cleared for the safe and effective simultaneous reduction of fat from the hips, waist and thighs. Primcogent Solutions’ revolutionary non-invasive body contouring technology, along with its unique physician business model, enhances practice profitability by eliminating the risks associated with purchasing capital equipment. For more information visit www.primcogent.com.
Erchonia is the global leader in low level laser healthcare applications. Over the last 15 years Erchonia has been conducting research & development with the world’s leading physicians to advance the science of low level lasers. Prior to market introduction, all Erchonia lasers are proven to be safe and effective through independent clinical trials. Currently thousands of Erchonia’s lasers are used daily to reduce body fat, eliminate pain, accelerate healing, and treat acne. For additional information, visit www.erchonia.com.